Caryn Anderton, the Director of Marketing for Signal Genetics, was kind enough to provide a blog post on Gene Expression Profiling. It is titled “What’s in your Genes?, and follows my brief introduction. The best and most knowledgeable and progressive myeloma specialists have embraced risk assessment to help map the best and most appropriate treatment for their myeloma patients. I am often shocked to find out many myeloma patients have no idea whether they are high or low risk, or what chromosome abnormalities they may have. I can only assume one of several reasons for this to occur– the most likely being doctors and patients do not know where to get the test completed, the doctors do the test and just do not see the need to educate their patients, or they do not do the testing from a lack of experience with myeloma. The European Myeloma Network recommends Gene Expression Profiling for multiple myeloma patients. This recommendation came in March of 2014 and you can read about it if you CLICK HERE. GEP is also included in the U.S. National Comprehensive Cancer Network and the International Myeloma Working Group guidelines. Caryn’s in depth blog post follows.
Good luck and God Bless your Myeloma Journey/ firstname.lastname@example.org